Highest-materiality recent filing
SRX Global declares $0.05/share dividend, authorizes $20M buyback, reports $3.07 NAV
One-time cash dividend of $0.05/share (~$1M aggregate) payable Aug 3, 2026 to holders of record July 22, 2026.
SRX Global receives NYSE American delisting notice; approves 1-for-60 reverse split effective July 6
NYSE American notified SRX on June 23, 2026 that stock closed below $0.10 and trading halted; company aims to regain compliance via reverse split.
SRx Health closes EMJX acquisition, changes name to SRX Global, issues 268M+ shares and warrants
Acquired 100% of EMJ Crypto Technologies and CCC Crypto; issued 268.3M common shares, 117.3M exchangeable shares, and 44.4M warrants.
SRx Health subsidiary invests >10% of investable capital in AI/space SPV
Halo, Purely for Pets invests >10% of investable capital in Astro Investment XVII, an Astro Capital affiliate SPV.
SRx Health Solutions and EMJX Update Merger Progress, Report Treasury Returns
Deployed $18M into Gen2 digital-asset treasury hedging strategy, March 2026 return of 5.69% vs S&P 500 decline of 4.98%.
SRx Health Solutions raises up to $8.0M via Series B preferred and warrants; initial close $4.528M
Securities Purchase Agreement for up to 10,000 Series B shares ($1,000 stated value) and warrants at $0.3182 exercise price.
SRx Health Solutions receives NYSE American warning letter over 7.5M share issuance without approval
NYSE American issued public warning letter on Feb 18, 2026 citing violations of Sections 301 and 713.
SRx Health redeems Series A Preferred for $21.8M, cancels ~125M common shares
Redeemed 17,418 Series A Preferred shares at ~$21.77M; all outstanding shares eliminated.
NYSE American accepts SRx Health's compliance plan; listing extended to July 14, 2026
NYSE accepted plan to regain compliance with Sections 1003(a)(i) and (ii) of the NYSE American Company Guide.
SRx Health shareholders OK name change to EMJX, EMJ Crypto acquisition
Stockholders approved name change to EMJX, Inc. and ticker to EMJX, conditioned on closing of transaction.
Aggregate purchase price ~$55M payable in stock; transaction unanimously approved by SRx Health Board.
First closing of private placement: 19,035 Series A Preferred shares and 54.5M warrants for $15.23M; additional closings at investor option up to $30.46M total.
SRx Health stockholders approve 25x share increase and up to 85:1 reverse split
Authorized shares increased from 200M to 5B; additional reverse split range 15:1 to 85:1 approved.
SRx Health Solutions dismisses auditor, enters CCAA asset sales; identifies $1.8M revenue error
Dismissed CBIZ CPAs, engaged Davidson & Company as auditor for FY2025 ending Sept 30.
SRx Health cancels 18.8M shares (60% of total) via settlement; director resigns
18.8M shares forfeited and canceled, representing ~60% of total outstanding Common Stock and Exchangeable Shares.
SRx Health Solutions' Canadian subsidiary enters CCAA restructuring; DIP financing obtained
SRx Canada obtained Initial Order under CCAA from Ontario Superior Court, including a stay of proceedings.
SRx Health appoints Kent Cunningham CEO; Adesh Vora becomes Executive Chairman; CFO gets raise
Adesh Vora resigned as CEO July 8; replaced by Kent Cunningham, previously President.
SRx Health closes $7.3M convertible note financing and secures $50M equity line of credit
Closed $7.3M convertible note financing led by insiders and existing investors; notes bear 8% interest, mature July 2027.
SRx Canada revenue C$200.5M for year ended Sep 30, 2024, net loss C$59.4M vs loss C$15.1M prior year.
SRx Health Solutions appoints new CEO, President, Chairman and CFO
Davender Sohi resigned as President effective June 10, 2025; no dispute cited.
SRx Health completes reverse merger with Better Choice; rename, new board, $8.8M PIPE
Former SRx Health stockholders own ~84% of combined entity; Better Choice holders retain ~16% (5.4M shares).
SRx Health Solutions replaces auditor Marcum with CBIZ CPAs; ongoing material weaknesses
Marcum LLP resigned as auditor April 23, 2025; CBIZ CPAs engaged immediately for FY 2025.
Stockholders of record as of April 23, 2025 receive one share of Halo SPV Class A Common Stock per share of common stock held.
Better Choice sells Asian business for $8.1M; $6.5M cash upfront, 5-year royalty
Sale of Halo's Asian business to CZC Company LTD for total gross proceeds of $8.1 million.
Better Choice confirms SRx acquisition consideration of 30M shares; closing targeted April 25
Addendum fixes aggregate consideration at 30,000,000 Better Choice common shares for SRx shareholders.
Better Choice shareholders approve name change to SRX Health Solutions and SRx acquisition
Shareholders approved name change to SRX Health Solutions Inc. and ticker to SRXH (FOR 1,359,116 votes).
Better Choice adjourns special meeting for SRx arrangement to March 21; 71% of shares voted in favor
Special meeting convened and immediately adjourned to March 21, 2025; no business conducted.
Better Choice amends SRx acquisition: valuation cut to $77M, closing deadline extended to Feb 28
Amendment No. 2 to Arrangement Agreement extends Outside Date from Jan 31, 2025 to Feb 28, 2025.
Better Choice posts investor presentation referencing proposed SRx deal; proxy solicitation underway
Company filed an updated investor presentation dated Oct 30, 2024 as Exhibit 99.1.
Combined 2025 pro forma revenue over $270M and EBITDA over $10M, based on management assumptions.
Better Choice Co. acquires SRx Health Solutions in all-stock deal valuing SRx at $80M
SRx to be acquired via statutory amalgamation; equity value $80M, assumes $43M net debt subject to two-way adjustment.
Better Choice Q2 net income $2.7M (EPS $2.98) vs $3.0M loss YoY; rev down 19%
Net income of $2.7M in Q2 2024 vs $3.0M loss a year ago; EPS $2.98 vs $(4.27).
Better Choice raises $5M in public offering of stock and pre-funded warrants
Sold 639,000 shares at $3.00 and 1,028,000 pre-funded warrants at $2.99 each.
NYSE American accepts Better Choice's compliance plan, extends listing through Oct 2025
On July 9, 2024, NYSE American accepted Better Choice's plan to regain compliance with continued listing standards.
Better Choice dismisses BDO, appoints Marcum; BDO's reports had going concern
On July 12, 2024, the Board dismissed BDO USA, P.C. as auditor and engaged Marcum LLP for FY2024.
Better Choice settles Alphia lawsuit, retires $5.0M senior secured debt and warrants
Retired $5.0M principal + $0.4M PIK interest senior secured debt with Alphia.
On June 10, 2025, SRx Health Solutions, Inc. (the “ Company ”) accepted the voluntary resignation of Davender Sohi as the President of the Company, effective immediately.
Kent Cunningham, 54, has been appointed as President of the Company; Adesh Vora, 49, has been appointed as Chief Executive Officer of the Company; and Lionel Conacher, 62, has been appointed as Chairman of the Board, in each case effective June 11, 2025.
Kent Cunningham, 54, has been appointed as President of the Company; Adesh Vora, 49, has been appointed as Chief Executive Officer of the Company; and Lionel Conacher, 62, has been appointed as Chairman of the Board, in each case effective June 11, 2025.
Kent Cunningham, 54, has been appointed as President of the Company; Adesh Vora, 49, has been appointed as Chief Executive Officer of the Company; and Lionel Conacher, 62, has been appointed as Chairman of the Board, in each case effective June 11, 2025.
On April 3, 2024, the Board appointed Kent Cunningham, the Company’s Chief Executive Officer, as a director of the Company, effective immediately,
Arlene Dickinson resigned from the Board of Directors (the “Board”) of Better Choice Company Inc., a Delaware corporation (the “Company”) and all committees of the Board effective as of April 1, 2024.
Donald Young, age 59, has resigned from his role as Chief Sales Officer of the Company, effective September 8, 2023.
Carolina Martinez, age 33, was appointed as Chief Financial Officer of the Company, effective August 2, 2023.
Lionel F. Conacher, age 60, will resign from his role as Interim Chief Executive Officer of the Company, effective May 22, 2023.
On May 11, 2023, the Company announced that Kent Cunningham, age 52, was appointed as Chief Executive Officer of the Company, effective May 22, 2023.
Sharla A. Cook, age 42, has resigned from her role as Chief Financial Officer, Secretary and Treasurer of the Company, effective April 3, 2023
Carolina Martinez, age 33, was appointed as Interim Chief Financial Officer, Secretary and Treasurer of the Company, effective April 3, 2023
Max materiality 0.90 · Median 0.70 · Most common event other_material